Study on metabonomic characteristics of human lung cancer using high resolution magic-angle spinning 1H NMR spectroscopy and multivariate data analysis

Magnetic Resonance in Medicine

Volumn 66, Issue 6, 2011, Pages 1531-1540

  Chen, Wenxue ^a,b   Zu, Yukun ^c   Huang, Qi ^c   Chen, Fener ^b   Wang, Guifang ^b   Lan, Wenxian ^a,d   Bai, Chunxue ^b   Lu, Shaohua ^b   Yue, Yong ^a   Deng, Feng ^a  

^a Wuhan National Laboratory for Optoelectronics   (China)

^b FUDAN UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY   (China)

Author keywords

HRMAS NMR spectroscopy; lung cancer; metabonomics; multivariate data analysis; OPLS DA; PCA

Indexed keywords

AMINO ACIDS; BIOLOGICAL ORGANS; DATA HANDLING; DIAGNOSIS; DISCRIMINANT ANALYSIS; DISEASES; FATTY ACIDS; HISTOLOGY; LEAST SQUARES APPROXIMATIONS; METABOLISM; METABOLITES; MULTIVARIANT ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SPECTRUM ANALYSIS; TISSUE;

HR-MAS NMR; LUNG CANCER; METABONOMICS; MULTIVARIATE DATA ANALYSIS; OPLS-DA;

MAGIC ANGLE SPINNING;

ASPARTIC ACID; FATTY ACID; GLUCOSE; GLYCEROPHOSPHORYLCHOLINE; LACTIC ACID; PHOSPHORYLCHOLINE; VALINE;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; DATA ANALYSIS; DISCRIMINANT ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; MESOTHELIOMA; METABOLITE; MULTIVARIATE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROMETER;

EID: 80655128256     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22957     Document Type: Article

References (35)

1. Pirozynski M,. 100 years of lung cancer. Respir Med 2006; 100: 2073-2084.
2. Schwartz AG, Prysak GM, Bock CH, Cote ML,. The molecular epidemiology of lung cancer. Carcinogenesis 2007; 28: 507-518.
3. Parkin DM, Bray F, Ferlay J, Pisani P,. Global cancer statistics, 2002. CA-Cancer J Clin 2005; 55: 74-108.
4. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ,. Cancer statistics, 2008. CA-Cancer J Clin 2008; 58: 71-96.
5. Yu YY, Pinsky PF, Caporaso NE, Chatterjee N, Baumgarten M, Langenberg P, Furuno JP, Lan Q, Engels EA,. Lung cancer risk following detection of pulmonary scarring by chest radiography in the prostate, lung, colorectal, and ovarian cancer screening trial. Arch Intern Med 2008; 168: 2326-2332.
6. Oken MM, Marcus PM, Hu P, Beck TM, Hocking W, Kvale PA, Cordes J, Riley TL, Winslow SD, Peace S, Levin DL, Prorok PC, Gohagan JK,. Baseline chest radiograph for lung cancer detection in the randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. J Natl Cancer Inst 2005; 97: 1832-1839.
7. Suryanto A, Herlambang K, Rachmatullah P,. Comparison of tumor density by CT scan based on histologic type in lung cancer patients. Acta Medica Indon 2005; 37: 195-198.
8. Gaber KA, Goldman JM, Farrell DJ,. Cytological examination of the whole endobronchial brush in bronchoscopic diagnosis of lung cancer. Respir Med 2002; 96: 259-261.
9. Erasmus JJ, Sabloff BS,. CT, positron emission tomography, and MRI in staging lung cancer. Clin Chest Med 2008; 29: 39-57.
10. Fletcher JW,. PET scanning and the solitary pulmonary nodule. Semin Thorac Cardiovasc Surg 2002; 14: 268-274.
11. Coleman RE,. PET in lung cancer staging. Quart J Nucl Med 2001; 45: 231-234.
12. Cheng LL, Chang IW, Louis DN, Gonzalez RG,. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. Cancer Res 1998; 58: 1825-1832.
13. 1H NMR spectroscopy of intact liver and kidney: optimization of sample preparation procedures and biochemical stability of tissue during spectral acquisition. Anal Biochem 2000; 282: 16-23.
14. 13C magic angle spinning NMR spectroscopy of rat liver. Magn Reson Med 2000; 44: 201-207.
15. 1H NMR and magic angle spinning NMR spectroscopic investigation of the biochemical effects of 2-bromoethanamine in intact renal and hepatic tissue. Magn Reson Med 2001; 45: 781-790.
16. 1H NMR spectroscopy reveals different responses in choline-containing metabolites upon gene therapy-induced programmed cell death in rat brain glioma. NMR Biomed 2005; 18: 252-259.
17. 1H NMR spectroscopy. NMR Biomed 2006; 19: 90-100.
18. Cheng LL, Chang IW, Smith BL, Gonzalez RG,. Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy. J Magn Reson 1998; 135: 194-202.
19. 1H NMR spectroscopy at 9.4 T. FEBS Lett 2001; 494: 112-116.
20. Lindon JC, Holmes E, Nicholson JK,. Pattern recognition methods and applications in biomedical magnetic resonance. Prog Nucl Magn Reson Spectrosc 2001; 39: 1-40.
21. Jordan KW, Adkins CB, Su L, Halpern EF, Mark EJ, Christiani DC, Cheng LL,. Comparison of squamous cell carcinoma and adenocarcinoma of the lung by metabolomic analysis of tissue-serum pairs. Lung Cancer 2010; 68: 44-50.
22. 1H high resolution magic angle spinning (HRMAS) NMR spectroscopy. J Proteome Res 2010; 9: 319-332.
23. Bylesjo M, Rantalainen M, Cloarec O, Nicholson JK, Holmes E, Trygg J,. OPLS discriminant analysis combining the strengths of PLS-DA and SIMCA classification. J Chemometrics 2006; 20: 341-351.
24. 13C NMR spectroscopy. Magn Reson Med 1988; 7: 384-411.
25. 1H nuclear magnetic resonance spectroscopy of tissue extracts and discriminant factor analysis. Magn Reson Med 1993; 29: 436-440.
26. 13C-NMR. NMR Biomed 2003; 16: 370-399.
27. Tong Z, Yamaki T, Harada K, Houkin K,. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard. Magn Reson Imaging 2004; 22: 1017-1024.
28. 1H-MRS as prognostic parameters in patients with non-small-cell lung cancer. J Magn Reson Imaging 2007; 25: 992-999.
29. 1H NMR. NMR Biomed 2008; 21: 1138-1147.
30. Podo F,. Tumour phospholipid metabolism. NMR Biomed 1999; 12: 413-439.
31. Tayek JA,. A review of cancer cachexia and abnormal glucose metabolism in humans with cancer. J Am Coll Nutr 1992; 11: 445-456.
32. 31P magnetic resonance spectroscopy in vivo. Clin Sci 2000; 98: 167-174.
33. Chiarla C, Giovannini I, Boldrini G, Castagneto M,. The branched-chain amino acids. Miner Gastro Diet 1997; 43: 189-196.
34. Eley HL, Russell ST, Tisdale MJ,. Effect of branched-chain amino acids on muscle atrophy in cancer cachexia. Biochem J 2007; 407: 113-120.
35. Kovacevic Z, Popovic J, Brkljac O, Lelas S,. Interaction of metabolism of aspartate and inosine and energy state of malignant cells. Biochem J 1987; 247: 47-51.